Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration

Table 6 Area under the curve for training, tenfold cross-validation and independent validation on 13-SNP model

Stage	Control/ CNV	ROC area	Standard error	Confidence limits
Training	467/482	0.82	0.01	0.79	0.85
Tenfold cross- validation	467/482	0.81	0.01	0.79	0.84
Validation	322/632	0.80	0.02	0.77	0.83

SNP, single nucleotide polymorphism; CNV, choroidal neovascular; ROC, receiver operating characteristic

ISSN: 1479-7364